ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EDEN Eden Research Plc

4.85
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.85 4.70 5.00 4.95 4.85 4.95 383,710 08:00:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -11.55 25.87M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.85p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £25.87 million. Eden Research has a price to earnings ratio (PE ratio) of -11.55.

Eden Research Share Discussion Threads

Showing 6851 to 6874 of 17800 messages
Chat Pages: Latest  280  279  278  277  276  275  274  273  272  271  270  269  Older
DateSubjectAuthorDiscuss
28/6/2019
11:51
OPTIONS RNS

"In respect of 2018:

· To the CEO Sean Smith nil cost options over 1,688,889 ordinary shares.
· To the CFO Alex Abrey nil cost options over 1,333,333 ordinary shares.

The vesting date of the options is 30 June 2022, and they only become exercisable if the following share price performance conditions are met: 50% of the options become exercisable if the weighted average Ordinary Share price in the 45-day period ending on the vesting date is £0.25 or above. Between weighted average Ordinary Share prices of £0.25 and £0.375, vesting shall be pro-rata and on a straight-line basis between 50% and 100%. Below £0.25 the options are not exercisable and lapse in full."


That is either not very stretching or a total gift given the current share options which have their ending date 30th September 2018. It absolutely seems like the latter to me. I'd rather they had more options, but at a much higher price!

What is it with AIM and its total lack of guidance & morality around the issue of options, remuneration committee's and alike. It's appalling.

investingisatrickygame
28/6/2019
11:48
Cheers guys..it's easy to forget how much potential the company has, something has to break soon.
33mick
28/6/2019
11:27
Life Expectancy Falters in the UK: Slow Death but Fast Profits for the Agrochemical Sector



A special report in the Observer newspaper in the UK on 23 June 2019 asked the question: Why is life expectancy faltering? The piece noted that for the first time in 100 years, Britons are dying earlier. The UK now has the worst health trends in Western Europe.

Aside from the figures for the elderly and the deprived, there has also been a worrying change in infant mortality rates. Since 2014, the rate has increased every year: the figure for 2017 is significantly higher than the one in 2014. To explain this increase in infant mortality, certain experts blame it on ‘austerity’, fewer midwives, an overstrained ambulance service, general deterioration of hospitals, greater poverty among pregnant women and cuts that mean there are fewer health visitors for patients in need.

While all these explanations may be valid, according to environmental campaigner Dr Rosemary Mason, there is something the mainstream narrative is avoiding. She says:
“We are being poisoned by weedkiller and other pesticides in our food and weedkiller sprayed indiscriminately on our communities. The media remain silent.”

supersonico
28/6/2019
11:02
Commercial news about these will give it a nudge.

Molluscicide news
Insecticide news
Wider Mevalone application label extensions TRIGEMOL / EUGETI / CAGENOLETA
Post Harvest/ other Seipro products from Sumiagro/Sipcam
Cedroz registrations/ Mevalone approval
EGTOP Organic announcement Eugenol / Thymol / Geraniol
Strategic update/strategic investor/
Bayer news
TT news
Bayer / TT parallel delay revelation..
Sustaine news from Sipcam and collaborators / Eastman
Field crops trials Cotton/wheat/soybean / 'highly potent active agent encapsulated' news
Anti-microbial news Xinova
Any pipeline news SC Johnson
Collaboration with DE SANGOSSE biocontrôle anti-mildiou PommeDeTerre.

supersonico
28/6/2019
10:37
"what's next to look forward too"

Well if we had that reliable information we wouldn't be sat at a paltry 11.5p

Whether you look forward to the following, who knows.

1) The Chairman originally said he would buy double what he has, so maybe further purchases to come, in short order :)
2) TT zzzzzzz
3) Bayer zzzzzzz
4) Sipcam evaluation of Sustaine and a commercial arrangement around the same

I wouldn't look to far beyond that to be honest in terms of 'short order'

A bit of support from our brokers and PR firm wouldn't go a miss.

A bit more bullishness from our Company, within the realms of fair value wouldn't go a miss either.

It seems to me that Eden's shares are suffering from long-term MDD :)

"Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of low mood that is present across most situations. It is often accompanied by low self-esteem, loss of interest in normally enjoyable activities, low energy, and pain without a clear cause. People may also occasionally have false beliefs or see or hear things that others cannot"

investingisatrickygame
28/6/2019
10:12
well that Buy was a long time coming,
Cheer me up and remind me guys what's next to look forward too
On the short order menu of news!
I'm hanging in there...Every share has its Day...In the Sun..ours is well overdue

33mick
28/6/2019
09:59
Finally....
bjlk
28/6/2019
09:43
11.5p, we'll soon be getting a nose bleed :)
investingisatrickygame
28/6/2019
08:13
27-Jun-19
Buy

Lykele van der Broek
10.5
GBX
40,000
180000
27-Jun-19
Buy

Lykele van der Broek
10.47
GBX
40,000
180000
27-Jun-19
Buy

Lykele van der Broek
10.75
GBX
40,000
180000
27-Jun-19
Buy

Lykele van der Broek
10.74
GBX
100,000
180000
27-Jun-19
Buy

Lykele van der Broek
11.41
GBX
138,500
358500

supersonico
28/6/2019
07:52
Hope so. Quite reassuring to see a 7% move on a purchase of only 35 grand or so. He's obviously had so many people ask him when he's buying shares he eventually caved in.
dplewis1
28/6/2019
07:29
At last. First purchase of two?
brucie5
28/6/2019
07:13
Is Michael Walters still around?
purplepelmets
28/6/2019
07:10
Nice buy from Short Order Lykele.
supersonico
28/6/2019
07:04
Finally.. Lykele has bought some shares!!
dplewis1
27/6/2019
18:44
Always fun to observe the purest of pure serendipity of unrelated Eden investors.
supersonico
27/6/2019
16:50
113,500 Buy at 11.50p,will we get RNS tomorrow?
monet
27/6/2019
13:04
Mrs $$New York :)

wan
31 Jul '19 - 07:37 - 564 of 564
0 0 0
Brucie...I agree that the initial market for Mevalone appears small in comparison. However, Sipcam's exclusivity for Mevalone would suggest they are expecting to address a much larger market going forwards. In this regard, I would imagine they are, at the very least, as 'proactive' as Sumi-Agro in this regard.

In my opinion it is instructive, in terms of the efficacy of Eden's products, product withdrawals, user/consumer backdrop and indeed the regulatory backdrop, that Eden has now been granted three emergency use authorisations....and in the absence/progress of full approval, I would not be surprised to see Eden receive further emergency use authorisations!

supersonico
27/6/2019
12:04
Looks like Mrs 51k is back buying
northwick
27/6/2019
09:28
More trades than posts on the bb today, things are looking up!
dplewis1
27/6/2019
08:33
Oh dear, I hope they don't start thinking that they are the master race and invade Poland.
weyweyumfozo
25/6/2019
18:29
Eden Research @edenresearch

Eden Research plc Retweeted The Biopesticide Summit 2019
Felicity Lenyk will be presenting on Eden's #Sustaine encapsulation technology at the @biosummit19 on the 2-3rd July in Swansea.

Felicity Lenyk from @edenresearch
and
Majda Ortan from #PHAgrohom adding to our line up, both very inspiring women!

supersonico
25/6/2019
18:09
BBC Radio 4 today

Among others, plastic and shampoo

investingisatrickygame
25/6/2019
15:55
Grateful to Super for putting me onto this guy. This video of a lecture in Germany is of material interest to what EDEN provide, including, 16 minutes in, a mention of the risk posed by canine flea treatments.

3/4 of the world's bees have neonicotinoids in their foods.

brucie5
25/6/2019
15:40
I wonder if EDEN should give these guys a call.
brucie5
Chat Pages: Latest  280  279  278  277  276  275  274  273  272  271  270  269  Older

Your Recent History

Delayed Upgrade Clock